Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Goodwill: 2020-2024

Historic Goodwill for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $159.9 million.

  • Maravai Lifesciences Holdings' Goodwill fell 24.66% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year decrease of 24.66%. This contributed to the annual value of $159.9 million for FY2024, which is 50.96% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Goodwill of $159.9 million as of FY2024, which was down 50.96% from $326.0 million recorded in FY2023.
  • Maravai Lifesciences Holdings' Goodwill's 5-year high stood at $326.0 million during FY2023, with a 5-year trough of $152.8 million in FY2021.
  • In the last 3 years, Maravai Lifesciences Holdings' Goodwill had a median value of $283.7 million in 2022 and averaged $256.5 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Goodwill spiked by 85.67% in 2022, and later crashed by 50.96% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Goodwill (Yearly) stood at $224.3 million in 2020, then slumped by 31.88% to $152.8 million in 2021, then skyrocketed by 85.67% to $283.7 million in 2022, then increased by 14.92% to $326.0 million in 2023, then tumbled by 50.96% to $159.9 million in 2024.